Application Nr Approved Date Route Status External Links
ANDA207672 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Paricalcitol Is A Vitamin D Analog Indicated In Adults For The Prevention And Treatment Of Secondary Hyperparathyroidism Associated With: Chronic Kidney Disease (ckd) Stages 3 And 4 (1.1) . Ckd Stage 5 In Patients On Hemodialysis Or Peritoneal Dialysis (1.2) . 1.1 Chronic Kidney Disease Stages 3 And 4 Paricalcitol Capsules Are Indicated In Adults For The Prevention And Treatment Of Secondary Hyperparathyroidism Associated With Chronic Kidney Disease (ckd) Stages 3 And 4. Pediatric Use Information For Patients 10 To 16 Years Of Age Is Approved For Abbvie Inc.’s Zemplar (paricalcitol) Capsules. However, Due To Abbvie Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information. 1.2 Chronic Kidney Disease Stage 5 Paricalcitol Capsules Are Indicated In Adults For The Prevention And Treatment Of Secondary Hyperparathyroidism Associated With Ckd Stage 5 In Patients On Hemodialysis (hd) Or Peritoneal Dialysis (pd). Pediatric Use Information For Patients 10 To 16 Years Of Age Is Approved For Abbvie Inc.’s Zemplar (paricalcitol) Capsules. However, Due To Abbvie Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paricalcitol PARICALCITOL ZINC13911941

Comments